Cleocin Phosphate Clindamycin Injection is an antibiotic medication used to treat serious bacterial infections. It comes in a vial containing 6 mL and has a concentration of 150 mg/mL. Each box contains 25 vials. It is primarily used for the treatment of infections such as pneumonia, skin and soft tissue infections, and bone infections. It works by stopping the growth of bacteria that cause these infections. This medication should only be administered under the supervision of a healthcare professional.
There are several benefits for using Pfizer USPG Cleocin Phosphate Clindamycin Injection:
- Effective Treatment for Bacterial Infections: This medication is prescribed to treat severe bacterial infections, including pneumonia, skin infections, and blood infections. It belongs to the category of antibiotics known as lincosamides, and it works by inhibiting the growth of bacteria.
- Flexible Dosing Options: This medication is available in different strengths (150mg/mL and 300mg/mL) and sizes (6mL and 25mL). This allows doctors to tailor the dosage according to an individual's specific medical condition, ensuring effective treatment with minimum risk of side effects.
- Quick Action: Due to its injectable form, it gets absorbed into the bloodstream quickly, allowing for a faster onset of action compared to oral medications. This can be especially useful in cases where a patient needs immediate treatment for a severe infection.
- Convenient Administration: Cleocin Phosphate is administered intravenously by a healthcare professional, making it an easy option for patients who cannot take oral medications due to nausea/vomiting or those who may have trouble swallowing pills.
- Reliable Antimicrobial: Clindamycin has been used as an antimicrobial agent for decades, making it well-studied and considered safe by most healthcare professionals.
- Approved by FDA: Pfizer USPG Cleocin Phosphate Clindamycin Injection is approved by the Food and Drug Administration (FDA), indicating its safety and efficacy.
- Potential Cost Savings: Pfizer USPG Cleocin Phosphate Clindamycin Injection is available in generic form, which could mean cost savings compared to brand-name medications.
- Serious lower respiratory tract infections: Including pneumonia and lung abscess caused by anaerobes, streptococci, staphylococci, and pneumococci susceptible to clindamycin
- Skin and soft tissue infections: Including cellulitis, wound infections, and necrotising fasciitis involving susceptible gram-positive and anaerobic organisms
- Septicemia: Caused by susceptible staphylococci and streptococci; often used as part of combination therapy
- Intra-abdominal infections: Peritonitis and intra-abdominal abscess — typically used in combination with a gram-negative agent given clindamycin's limited aerobic gram-negative coverage
- Female pelvic and genital tract infections: Including endometritis, pelvic inflammatory disease, and post-surgical infections involving anaerobes
- Bone and joint infections: Including acute hematogenous osteomyelitis caused by Staphylococcus aureus; clindamycin achieves good bone penetration
- Clinical note: Susceptibility testing is required prior to use, particularly for MRSA isolates — inducible resistance (D-zone positive) precludes clindamycin use regardless of initial disk diffusion results
This product is intended for use by qualified healthcare professionals or under the guidance of a licensed medical provider. It is not a substitute for professional medical advice, diagnosis, or treatment.
- Black Box Warning - C. difficile-Associated Diarrhea (CDAD): Clindamycin has been associated with severe and potentially fatal colitis caused by Clostridioides difficile. CDAD must be considered in any patient presenting with diarrhea during or after clindamycin therapy. Discontinue use if CDAD is suspected or confirmed.
- Hypersensitivity reactions: Serious reactions including anaphylaxis and severe skin reactions have been reported. Discontinue immediately if a severe allergic reaction occurs. Do not use in patients with known hypersensitivity to clindamycin or lincomycin.
- IV administration requirements: Must be diluted before intravenous infusion. Do not administer as an IV bolus. Infusion rate must not exceed 30 mg/minute - rapid infusion is associated with hypotension and cardiorespiratory arrest.
- Use with caution: In patients with a history of gastrointestinal disease (particularly colitis), hepatic impairment, or atopic conditions. Monitor liver function in prolonged courses.
- Neuromuscular blockade: Clindamycin has neuromuscular blocking properties and may potentiate the effects of other neuromuscular blocking agents - use with care in patients receiving such agents.
- Prescription only: This product is for use by or under the supervision of a licensed healthcare professional. Not for consumer purchase or self-administration.
This product is intended for use by qualified healthcare professionals or under the guidance of a licensed medical provider. It is not a substitute for professional medical advice, diagnosis, or treatment.
Cleocin Phosphate (Clindamycin Phosphate) Injection is a prescription-only (RX) pharmaceutical product regulated under U.S. federal law. It may only be dispensed by or upon the order of a licensed healthcare professional. This product is not for consumer purchase or personal use.
The clinical information provided on this page - including indications, dosing references, mechanism of action, and safety information - is intended for use by qualified healthcare professionals only. It is provided for informational and procurement reference purposes and does not constitute medical advice, clinical guidance, or a substitute for the full prescribing information issued by Pfizer USPG.
All prescribers and administering clinicians must review the complete Pfizer USPG Cleocin Phosphate prescribing information, including contraindications, warnings, drug interactions, and dosing instructions, before clinical use. Dosing and administration must be individualised based on patient-specific clinical factors and current clinical guidelines.
Mountainside Medical Equipment is a wholesale medical supply distributor and is not responsible for clinical outcomes associated with the use of this product. All clinical decisions remain the sole responsibility of the treating licensed healthcare professional.
This page references NDC 00009-0902-18 and manufacturer information as provided at the time of listing. Product availability, pricing, and specifications are subject to change. Contact Mountainside Medical sales for current availability confirmation before order placement.